Figure 11 — Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia

Research Paper|Volume 13, Issue 12|pp. 16445–16470

Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia

Back to articleFigure 11(11 of 13)

100%

Figure 11.The pathway enrichment in the high versus low ITGAM expression group is based on the TCGA-LAML expression profiles. The significant enriched KEGG pathways were confirmed as an enrichment when FDR < 0.05.